Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07236034 · ClinicalTrials.gov registry record · NA

ARISe at UMass Chan

A NA study of Vaccination and Vaccination Promotion, sponsored by University of Massachusetts, Worcester.

Recruiting
Registry status
NA
Development phase
700
Enrollment target
1
Study location

NCT07236034 is a NA study of Vaccination and Vaccination Promotion that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 700 participants, below the 10,175-participant average among 12 other Vaccination trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07236034, a NA study of Vaccination and Vaccination Promotion, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.

RECRUITING
Registry status
NA
Development phase
700 participants
Enrollment target
1
Study location

Study Summary

The goal is to identify the most impactful strategies for capturing attention and enhancing effectiveness of vaccine promotion messages. This will be done using an online survey that employs remote eye-tracking and self report measures to evaluate response to sample vaccine promotion social media content in rural populations in New England. Participants will be randomly assigned into one of 14 conditions in a 2(source: expert vs. influencer) by 7 (themes: constructs from 7C Vaccine Framework) experiment and view sample messages and then answer questions about their attitudes and beliefs while being monitored for eye-tracking.

Interventions

  • BEHAVIORAL Exposure to source and message content

Study Locations (1)

Massachusetts

  • University of Massachusetts Chan Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2025-12-01
Est. Completion 2026-09-30
Phase NA

What the Registry Record Tells You About NCT07236034

The ClinicalTrials.gov registry entry for NCT07236034 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,175-participant average among 12 other Vaccination trials with a reported enrollment target (93% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Exposure to source and message content is the first listed.

NCT07236034 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07236034 about?

NCT07236034 is a clinical study titled "ARISe at UMass Chan". The goal is to identify the most impactful strategies for capturing attention and enhancing effectiveness of vaccine promotion messages. This will be done using an online survey that employs remote eye-tracking and self report measures to evaluate response to sample vaccine promotion social media co...

What is the current status of trial NCT07236034?

This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2025-12-01. Estimated completion is 2026-09-30.

What conditions does trial NCT07236034 study?

This clinical trial studies the following conditions: Vaccination, Vaccination Promotion.

What interventions are being tested in trial NCT07236034?

The interventions under investigation include: Exposure to source and message content (BEHAVIORAL).

Who is sponsoring clinical trial NCT07236034?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07236034 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vaccination

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.